For many people, these medications reduce hunger, slow gastric emptying, and make it easier to maintain a calorie deficit
Then the dose escalations kick in, and weeks 6 through 8 become what trial participants called the survival phase. During these weeks, nausea rates peak at 28%
DW: Investigation, Writing original draft, Supervision, Methodology, Software, Resources, Formal analysis
GLP-1 Agonists: Mechanism and Clinical Outcomes Framework Both Contrave and GLP-1 medications suppress appetite but through fundamentally different biological routes
World patent WO2010059771 (2010)
GIP improves nutrient handling